Sabicard 50 mg is a film-coated tablet combining Sacubitril (24 mg) and Valsartan (26 mg), formulated as Sacubitril Valsartan Sodium Hemipentahydrate. This combination is designed to manage chronic heart failure (NYHA Class II–IV) by reducing the risk of cardiovascular death and hospitalization. Sacubitril inhibits neprilysin, increasing levels of natriuretic peptides, while Valsartan blocks angiotensin II receptors, leading to vasodilation and reduced blood pressure